Aura Biosciences, Inc.
AURAFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Aura Biosciences, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 16, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 2026-03-31 | 4,544 | $30.4K | SEC filing |
| CITIGROUP INC | 2026-03-31 | 12,482 | $83.5K | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 27,483 | $184K | SEC filing |
| Allworth Financial LP | 2026-03-31 | 745 | $4.99K | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2026-03-31 | 30,284 | $203K | SEC filing |
| GAMMA Investing LLC | 2026-03-31 | 860 | $5.75K | SEC filing |
| Medicxi Ventures Management (Jersey) Ltd | 2026-03-31 | 3,039,892 | $20.3M | SEC filing |
| NEW YORK STATE COMMON RETIREMENT FUND | 2026-03-31 | 13,104 | $87.7K | SEC filing |
| Permanent Capital Management, LP | 2026-03-31 | 62,369 | $440K | SEC filing |
| AQR CAPITAL MANAGEMENT LLC | 2026-03-31 | 46,143 | $309K | SEC filing |
| MetLife Investment Management, LLC | 2026-03-31 | 24,962 | $167K | SEC filing |
| LEVIN CAPITAL STRATEGIES, L.P. | 2026-03-31 | 941,400 | $6.3M | SEC filing |
| Susquehanna Portfolio Strategies, LLC | 2026-03-31 | 28,729 | $192K | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 11,397 | $76.2K | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 195 | $1.31K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 102,100 | $683K | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 2,869 | $19.2K | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 2,377 | $15.9K | SEC filing |
| 49 WEALTH MANAGEMENT, LLC | 2026-03-31 | 21,704 | $145K | SEC filing |
- Each value is checked against Aura Biosciences, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- 1 row left out: the value per share it reports is far from Aura Biosciences, Inc.'s share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Aura Biosciences, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-17 · Hopkins Janet Jill: Larger than 35 of the 38 other insider sales of Common Stock on file. SEC filing
- 2026-02-17 · de los Pinos Elisabet: Larger than all 38 other insider sales of Common Stock on file. SEC filing
- 2024-10-18 · de los Pinos Elisabet: Larger than 36 of the 38 other insider sales of Common Stock on file. SEC filing
- 2024-10-18 · Feder Julie B: Larger than 37 of the 38 other insider sales of Common Stock on file. SEC filing
- 2023-11-07 · Johnson David Michael: Larger than 18 of the 20 other insider purchases of Common Stock on file. SEC filing
- 2021-11-02 · Matrix Capital Management Company, LP: Larger than all 20 other insider purchases of Common Stock on file. SEC filing
- 2021-11-02 · Medicxi Growth I LP: Larger than 19 of the 20 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-05-16–2025-05-16: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-11-02–2021-11-02: 3 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-16 | Gibney Anthony S · See Remarks | Common Stock | S — Open market or private sale | −12,824 | 6.42 | SEC filing |
| 2026-05-07 | Matrix Capital Management Company, LP · 10% owner | Common Stock, par value $0.00001 per share (Common Stock) | S — Open market or private sale | −6,922,870 | 5.64 | SEC filing |
| 2026-04-16 | Kilroy Conor · See Remarks | Common Stock | S — Open market or private sale | −11,738 | 7.02 | SEC filing |
| 2026-02-17 | de los Pinos Elisabet · See Remarks | Common Stock | S — Open market or private sale | −47,648 | 5.06 | SEC filing |
| 2026-02-17 | Elazzouzi Amy · Senior Vice President, Finance | Common Stock | S — Open market or private sale | −8,549 | 5.06 | SEC filing |
| 2026-02-17 | Plavsic Mark · Chief Technology Officer | Common Stock | S — Open market or private sale | −15,890 | 5.05 | SEC filing |
| 2026-02-17 | Hopkins Janet Jill · Chief Medical Officer | Common Stock | S — Open market or private sale | −20,401 | 5.06 | SEC filing |
| 2026-02-17 | Kilroy Conor · See Remarks | Common Stock | S — Open market or private sale | −12,079 | 5.05 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Srivastava Sapna · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | Mattessich Antony C. · Director | Common Stock | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Johnson David Michael · Director | Common Stock | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Johnson David Michael · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | Mattessich Antony C. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
| 2026-06-11 | Bitetti Teresa Marie · Director | Common Stock | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Srivastava Sapna · Director | Common Stock | A — Grant, award, or other acquisition | +15,000 | SEC filing |
| 2026-06-11 | Bitetti Teresa Marie · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +30,000 | SEC filing |
Showing 8 of 21 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.